Bladder Neoplasm
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
In this study, microarray analysis was used to screen circRNA expression profiles of bladder cancer (BC) 5637 cells, T24 cells and normal control SV-HUC-1 cells.
|
31072448 |
2020 |
Bladder Neoplasm
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
On the contrary, overexpression of Sema4D in bladder cancer SV-HUC-1 cells significantly increased cell viability and motility.
|
30674231 |
2019 |
Bladder Neoplasm
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Compared with SV-HUC-1 cells, miR-155 expression in bladder cancer BIU-87 and 5637 cells was significantly increased, and GSK-3β expression was significantly decreased.
|
31298320 |
2019 |
Bladder Neoplasm
|
0.100 |
Biomarker
|
disease |
BEFREE |
The present study detected the expression of DUXAP10 in human normal bladder cell SV‑HUC‑1 and BC cell lines.
|
29115412 |
2018 |
Bladder Neoplasm
|
0.100 |
Biomarker
|
disease |
BEFREE |
Here, we report the increased expression of soluble ephrin-A1 (sEphrin-A1) in supernatants of BCa cell lines (RT4, T24, and TCCSUP) co-cultured with human umbilical vein endothelial cells (HUVECs) compared with that in immortalized uroepithelial cells (SV-HUC-1) co-cultured with HUVECs. sEphrin-A1 is released from BCa cells as a monomeric protein that is a functional form of the ligand.
|
29367676 |
2018 |
Bladder Neoplasm
|
0.100 |
Biomarker
|
disease |
BEFREE |
Furthermore, its expression was also reduced in several human BC cell lines (T24, HT-1376 and 5637) compared with that in the normal bladder epithelial SV-HUC-1 cell line.
|
30214503 |
2018 |
Bladder Neoplasm
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The expression of miR-1-3p in bladder cancer cells was downregulated as compared to normal SV-HUC-1 cells.
|
30458442 |
2018 |
Bladder Neoplasm
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Reverse transcription‑quantitative polymerase chain reaction demonstrated that miR‑214 was downregulated in bladder cancer tissues compared with the level in normal tissues. miR‑214 was downregulated in bladder cancer cell lines compared with the level in the normal cell line SV‑HUC‑1. miR‑214 mimics were transfected into T24 and J82 cell lines to restore its expression.
|
29328435 |
2018 |
Bladder Neoplasm
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
In this study, the expression of miR-1247 was significantly downregulated, while RAB36 protein was remarkably upregulated in bladder cancer tissues and cell lines compared with that in paired adjacent normal tissues or normal cell line (SU-HUC-1).
|
29872024 |
2018 |
Bladder Neoplasm
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
RT-qPCR and western blotting demonstrated that cytokines IL-2, IFN-α and IFN-γ markedly upregulated PD-L1 mRNA expression rates and protein levels in bladder cancer T24 cells (P<0.05), but had no significant effect in non-tumor SV-HUC-1 cells.
|
28599483 |
2017 |
Bladder Neoplasm
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
This study explored the regulative role of miR-34a on an orphan nuclear receptor HNF4G, which has a well-confirmed role in bladder tumor growth and invasion. qRT-PCR analysis was applied to measure miR-34a expression in two tumorigenic bladder cancer cell lines 5637 and T24 and one normal human urothelial cell line SV-HUC-1.
|
25878394 |
2015 |
Bladder Neoplasm
|
0.100 |
Biomarker
|
disease |
BEFREE |
The 5637 bladder cancer cell line and SV-HUC-1 normal uroepithelial cells were used to study expression of HMGA2, E-cadherin and vimentin using RT-PCR and western blotting.
|
24571540 |
2014 |
Bladder Neoplasm
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Expression of miR-493 in bladder cancer (T24, J82, and TCCSUP) cells was downregulated compared with normal SV-HUC-1 cells.
|
22057916 |
2012 |
Bladder Neoplasm
|
0.100 |
Biomarker
|
disease |
BEFREE |
Using PCR, 20 bladder tumours at differing stage and grade, a non-tumourigenic urothelial cell line (SV-HUC-1) and 17 bladder cancer cell lines were examined for expression of this alternatively spliced (AS) KAI1 mRNA.
|
17982617 |
2007 |